Literature DB >> 25723281

Generation of med28 specific monoclonal antibodies.

Min A Yu1, Jin Gu Cho, Kwang-Il Kim, Yeong Joon Jo, Jong-Hyuk Sung, Ho Bin Yang, Sang Gyu Park.   

Abstract

Med28 plays a role in transcription, signal transduction, and cell proliferation. The overexpression of med28 is associated with tumor progression in in vitro and in vivo models. Recently it has been reported that the elevated expression of med28 is associated with poor outcome in women with breast cancer. The expression level of med28 in in vitro and in vivo was examined by using anti-rabbit polyclonal antibody in previous reports. In this study, we report for the first time the generation and characterization of four monoclonal antibodies against med28 through immunoblotting, immunofluorescence microscopy, immunoprecipitation, and immunohistochemical analyses. These antibodies will be useful in detecting med28 in in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25723281      PMCID: PMC4350139          DOI: 10.1089/mab.2014.0068

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  12 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulation.

Authors:  Ming-Fen Lee; Roberta L Beauchamp; Kim S Beyer; James F Gusella; Vijaya Ramesh
Journal:  Biochem Biophys Res Commun       Date:  2006-07-31       Impact factor: 3.575

3.  The novel gene EG-1 stimulates cellular proliferation.

Authors:  Ming Lu; Liping Zhang; Raymond Scott Maul; Maryam R Sartippour; Andrew Norris; Julian Whitelegge; Jian Yu Rao; Mai N Brooks
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

4.  Identification of a novel endothelial-derived gene EG-1.

Authors:  Canhui Liu; Liping Zhang; Zhi-Ming Shao; Perrin Beatty; Maryam Sartippour; Timothy F Lane; Sanford H Barsky; Edward Livingston; Mai Nguyen
Journal:  Biochem Biophys Res Commun       Date:  2002-01-11       Impact factor: 3.575

5.  Monoclonal and polyclonal antibodies specific for foot and mouth disease virus type A and type O VP1.

Authors:  Jin Gu Cho; Yeong Joon Jo; Jong-Hyuk Sung; Jang-Kwan Hong; Ji-Hyeon Hwang; Jong-Hyeon Park; Kwang-Nyeong Lee; Sang Gyu Park
Journal:  Hybridoma (Larchmt)       Date:  2012-10

Review 6.  The merlin interacting proteins reveal multiple targets for NF2 therapy.

Authors:  Daniel R Scoles
Journal:  Biochim Biophys Acta       Date:  2007-10-12

7.  Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.

Authors:  Thorsten Wiederhold; Ming-Fen Lee; Marianne James; Ralph Neujahr; Nicole Smith; Anita Murthy; John Hartwig; James F Gusella; Vijaya Ramesh
Journal:  Oncogene       Date:  2004-11-18       Impact factor: 9.867

8.  Targeted inhibition of EG-1 blocks breast tumor growth.

Authors:  Ming Lu; Maryam R Sartippour; Liping Zhang; Andrew J Norris; Mai N Brooks
Journal:  Cancer Biol Ther       Date:  2007-03-26       Impact factor: 4.742

9.  Mediator subunit MED28 (Magicin) is a repressor of smooth muscle cell differentiation.

Authors:  Kim S Beyer; Roberta L Beauchamp; Ming-Fen Lee; James F Gusella; Anders M Näär; Vijaya Ramesh
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

10.  Elevated MED28 expression predicts poor outcome in women with breast cancer.

Authors:  Nam K Yoon; Erin L Maresh; Yahya Elshimali; Ai Li; Steve Horvath; David B Seligson; David Chia; Lee Goodglick
Journal:  BMC Cancer       Date:  2010-06-28       Impact factor: 4.430

View more
  2 in total

1.  MED28 increases the colony-forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage.

Authors:  Jin Gu Cho; Key-Hwan Lim; Sang Gyu Park
Journal:  Oncol Lett       Date:  2017-12-29       Impact factor: 2.967

2.  ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a.

Authors:  Jin Gu Cho; Seho Park; Chae Hyun Lim; Hong Sook Kim; Seung Yong Song; Tae-Young Roh; Jong-Hyuk Sung; Wonhee Suh; Seok-Jin Ham; Key-Hwan Lim; Sang Gyu Park
Journal:  Oncotarget       Date:  2016-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.